Skip Navigation

Link to  the National Institutes of Health NIDA NEWS NIDA News RSS Feed
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Keep Your Body Healthy
Go to the Home pageGo to the About Nida pageGo to the News pageGo to the Meetings & Events pageGo to the Funding pageGo to the Publications page
PhysiciansResearchersParents/TeachersStudents/Young AdultsEn Español Drugs of Abuse & Related Topics
NIDA Program Contacts
NIDA Genetics Programs
 
Return to Home Page
About Genetics Workgroup
Human Genetics Application Guidelines
NIDA Genetics News
NIDA Genetics Consortium
NIDA Recent Findings
NIDA Genetics Portfolio
NIDA Initiatives in Genetics
NIDA Meetings
NIDA Program Contacts
 

Resources for Genetics, Cell Biology, and Neuroscience
 
Calendar
Human Genetics
Tissue and Cell Repositories
Twin Registry
Nucleotide
Gene Expression
Genomes
Proteins
Model Organisms
Mouse
Knowledgebase for Addiction Related Genes (KARG)
Cell Biology
SfN Neuroscience Database
Gateway
Bibliographic Resources
 

Division of Epidemiology, Services, and Prevention Research (DESPR)

Kay L. Wanke, Ph.D., M.P.H. (wankek@mail.nih.gov)
Interests:
  Tobacco use and dependence, genetic epidemiology of vulnerability to drug use disorders, and phenotypes and endophenotypes of drug use and dependence.

Yonette F. Thomas, Ph.D. (ythomas@mail.nih.gov)
Interests:
 Epidemiology; social epidemiology; linking social and genetic epidemiology of drug abuse.

Naimah Weinberg, M.D. (nw46w@nih.gov)
Interests:
Psychiatric risk factors for drug abuse, comorbidity and common etiology of psychiatric and substance use disorders, genetic epidemiology of drug abuse vulnerability and comorbidity.

Division of Basic Neuroscience & Behavior Research (DBNBR)


Christine Colvis, Ph.D. (ccolvis@mail.nih.gov)
Interests: 
Proteomics, technology development, neuroscience and co-morbid conditions such as HIV and hepatitis C.

Diane M. Lawrence, Ph.D. (LawrenceDi@nida.nih.gov)
Interests: HIV/AIDS, neuropathogenesis, inflammation, neuroimmunology, neuron-glia interactions

Jonathan D. Pollock, Ph.D. (jp183r@nih.gov
Interests:
  Molecular genetics of substance abuse, molecular genetics of synaptic plasticity and memory, model organisms.

Joni L. Rutter, Ph.D. (jrutter@mail.nih.gov)
Interests:
  Human and population genetics, pharmacogenetics, gene x gene, gene x environment interactions, molecular genetics of drug addiction and addiction vulnerability, and ELSI issues.

John Satterlee, Ph.D (satterleej@nida.nih.gov)
Interests:  
Model organisms and behavioral genetics, RNAi and microRNAs, epigenetics, signal transduction.

David Shurtleff, Ph.D. (dshurtle@mail.nih.gov)
Interests:
Director, Division of Basic Neuroscience and Behavioral Research; genetics and molecular neurobiology of addiction; phenotypic characterization of genetic model organisms and substance use-related disorders.

Karen Skinner, Ph.D. (skinnerk@mail.nih.gov)
Interests:
  Systems biology, data integration, multilevel modeling, biomedical computation.

Susan Volman, Ph.D. (svolman@nida.nih.gov) 
Interests:  Behavioral genetics of drug abuse and of co-occuring disorders in animal models.

Da-yu Wu, Ph.D (wudy@mail.nih.gov)
Interests:  Neural development, molecular genetics, animal models, and RNAi.

Division of Clinical Neuroscience, Development and Behavioral Treatment (DCNDBT)

Kevin P. Conway, Ph.D. (kconway@nida.nih.gov)
Interests:
 Familial and genetic vulnerability, phenotypic heterogeneity of drug use disorders, environmental influences on the expression of liability, comorbid disruptive behavior problems, and temperament and personality, particularly behavioral disinhibition.

Harold Gordon, Ph.D. (hg23r@nih.gov)
Interests:
human genetics of drug abuse vulnerability and resilience, risks associated with early or chronic stress, interactions between drug use and sleep disturbances/circadian rhythms.

Division of Pharmacotherapies and Medical Consequences of Abused Drugs (DPMCAD)

William J. Glass, M.S. (jglass@nih.gov)
Interests:
pharmacogenomics and clinical informatics.

Jag H. Khalsa, Ph.D. (jk98p@nih.gov)
Interests: Genetics of metabolic (including nutritional) & endocrine disorders of drug abuse, co-occurring infections (HIV, hepatitis C, TB, STDs); genetics of drug-drug interactions among antiretrovirals, drugs of abuse and addiction treatment medications.

Iván D. Montoya, M.D., M.P.H. (imontoya@mail.nih.gov)
Interests:
Pharmacogenetics of the safety and efficacy of medications approved or being investigated for the treatment of substance use disorders.

Amrat P. Patel, Ph.D. (ap79g@nih.gov)
Interests:
Medication Development, Neurotransmitter Transporter Pharmacology, Pharmacokinetics, and Metabolism

Intramural Research Program


George Uhl, M.D. Ph.D. (guhl@intra.nida.nih.gov)
Interests:
Genetics and molecular neurobiology of addictions; Association genome scanning; Pooled association genome scanning
Office of Extramural Affairs.

Office of Extramural Affairs

Rita Liu, Ph.D. (rliu@nida.nih.gov)
Interests
: Receipt, referral and review of grant applications; neuroscience and molecular genetics and proteomics.

Mark R. Green, Ph.D (mg388g@nih.gov)
Interests
: Peer/Grant Review

Mark Swieter, PhD (ms80x@nih.gov)
Interests:
Training and Career Development and Peer/Grant Review

 
 
 
 
Any questions or concerns regarding the genetics programs please contact Jonathan D. Pollock Ph.D. (301) 443-1887 or jp183r@nih.gov


NIDA Home | Site Map | Search | FAQs | Accessibility | Privacy | FOIA (NIH) | Employment


National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Tuesday, March 11, 2008. The U.S. government's official web portal